Combination Medications in Diabetes Care: An Opportunity That Merits More Attention
Open Access
- 1 October 2003
- journal article
- Published by American Diabetes Association in Clinical Diabetes
- Vol. 21 (4), 175-178
- https://doi.org/10.2337/diaclin.21.4.175
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care settingClinical Therapeutics, 2003
- Polypharmacy and Medication Adherence in Patients With Type 2 DiabetesDiabetes Care, 2003
- Economic Model of First-Line Drug Strategies to Achieve Recommended Glycaemic Control in Newly Diagnosed Type 2 Diabetes MellitusPharmacoEconomics, 2003
- A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in ItalyClinical Therapeutics, 2002
- Factors Affecting Medication Adherence in Hypertensive PatientsAnnals of Pharmacotherapy, 2002
- Rationale for Fixed-Dose Combinations in the Treatment of HypertensionDrugs, 2002
- Utilization of Oral Hypoglycemic Agents in a Drug-Insured U.S. PopulationDiabetes Care, 2001
- Lack of adherence to lipid‐lowering drug treatment. A comparison of utilization patterns in defined populations in Funen, Denmark and Bologna, ItalyBritish Journal of Clinical Pharmacology, 2000
- The role of combination antihypertensive therapy and the progression of renal disease hypertension: looking toward the next millennium.American Journal of Hypertension, 1998
- Impact of Dosage Frequency on Patient ComplianceDiabetes Care, 1997